RECENT NEWS

A new partnership between Roche Diagnostics UK and Ireland, Newcastle University and The Newcastle upon Tyne Hospitals NHS Foundation Trust, will play a key role in developing cutting-edge medical diagnostics.

Women with worrying lumps are to be directly referred to a breast diagnostic clinic using the NHS App as part of a new trial, the Health and Social Care Secretary has announced. The hope is that this will lead to faster diagnosis for cancer patients and free up more GP appointments.

NHS maternity staff in England will take part in a new pilot programme to help reduce avoidable brain injuries in childbirth, the government has announced.

The Royal College of Pathologists (RCPath) is marking International Pathology Day on Wednesday 6 November with a day-long virtual conference looking at the issue of antimicrobial resistance (AMR).

The National Pathology Imaging Co-operative (NPIC) at Leeds Teaching Hospitals NHS Trust will receive £5.1 million from the Government to improve data infrastructure that will aid cancer and disease research – potentially leading to faster and more accurate diagnosis of cancer and other diseases.

Adsilico, a ground-breaking computational modelling company working with medical simulation and generative AI, recently completed a £3.5 million seed round investment, and now announces its first Chair, Chris Richardson.

The Medical Defence Union (MDU) has announces it’s sponsorship of the upcoming NHS Parliamentary Awards ceremony, which will be held in Westminster on Monday 14 October 2024.

Gloucestershire Hospitals NHS Foundation Trust has successfully gone live with Altera’s Sunrise Knowledge-based Medication Administration (KBMA) system, across all adult inpatient wards. This move enhances patient safety with closed-loop medicine administration and will accelerate digital maturity towards the HIMSS Electronic Medical Record Adoption Model (EMRAM) stage 6 target.

Clinicians working at five of the six trusts in the West Yorkshire Association of Acute Trusts (WYAAT) can access test results from across their pathology network, following a summer roll-out of Clinisys’ ICE OpenNet.

A new type of blood test using lipids could make it easier to identify children at risk of complications around obesity including type two diabetes, liver and heart disease, say scientists.

A Liberal Democrats survey says one in four people have avoided calling an ambulance because they thought it would take too long to arrive.

Hundreds of babies have begun to be tested for over 200 rare genetic conditions as part of a world-leading study in NHS hospitals that aims to screen up to 100,000 newborns in England.

DrDoctor, a leading patient engagement platform (PEP) supplier, has announced a new partnership with Countess of Chester Hospital NHS Foundation to empower operational and clinical teams to manage and scale hybrid patient pathways within the trust.

​Tens of thousands of children and eligible adults living with type 1 diabetes across England are set to receive an ‘artificial pancreas’ thanks to cost-effective deals secured by the NHS with suppliers of the technology.

​A new paper in the Journal of the National Cancer Institute, published by Oxford University Press, indicates that patients may benefit if doctors stop calling certain early-stage changes to the prostate 'cancer'.

Speaking at the Future Surgery event in London today, Tim Mitchell, President of the Royal College of Surgeons of England, warned the Government it will ‘fail to make a sufficient dent in reducing waiting times without investment in crumbling NHS infrastructure and new technology’.

Global leaders have approved a political declaration at the 79th United Nations General Assembly (UNGA) High-Level Meeting on Antimicrobial Resistance (AMR), committing to a clear set of targets and actions, including reducing the estimated 4.95 million human deaths associated with bacterial antimicrobial resistance (AMR) annually by 10% by 2030.

Around one in eight children aged between two and 10 in England are obese, an NHS survey has found.

A National Patient Safety Alert has been issued by the NHS England National Patient Safety team, endorsed by the Royal College of Obstetricians and Gynaecologists, Royal College of Midwives and Royal College of Anaesthetists, instructing all relevant NHS funded maternity care providers to cease pre-preparing oxytocin infusions at ward level in all clinical areas.

Diagnostic firm Cepheid has announced a new partnership with the Fleming Initiative, a global collaboration established by Imperial College Healthcare NHS Trust and Imperial College London to combat antimicrobial resistance (AMR).